A PHASE 2 INVESTIGATOR INITIATED STUDY TO DETERMINE THE EFFICACY AND SAFETY OF TVB-2640 IN COMBINATION WITH BEVACIZUMAB IN PATIENTS WITH FIRST RELAPSE OF HIGH GRADE ASTROCYTOMA
Principal Investigator(s)
Brenner,Andrew
Funded by
3-V BIOSCIENCES, INC.
Research Start Date
Status
Active